Aura Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aura Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Aura Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$21M, a 13.7% decline year-over-year.
  • Aura Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$83.2M, a 17.5% decline year-over-year.
  • Aura Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$76.4M, a 30% decline from 2022.
  • Aura Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$58.8M, a 66.7% decline from 2021.
  • Aura Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$35.3M, a 58.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$83.2M -$21M -$2.53M -13.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$80.7M -$20.3M -$2.04M -11.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$78.6M -$19.7M -$2.24M -12.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$76.4M -$22.1M -$5.57M -33.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$70.8M -$18.5M -$2.61M -16.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$68.2M -$18.3M -$4.83M -35.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$63.4M -$17.5M -$4.63M -36.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$58.8M -$16.6M -$4.93M -42.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$53.8M -$15.9M -$7.06M -79.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$46.8M -$13.5M -$4.62M -52.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$42.2M -$12.8M -$6.91M -117% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$35.3M -$11.6M -$6.73M -137% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$28.5M -$8.84M -$5.21M -143% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$23.3M -$8.85M -$2.7M -43.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$20.6M -$5.93M +$1.59M +21.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$22.2M -$4.91M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$3.63M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-24
Q2 2020 -$6.16M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-24
Q1 2020 -$7.51M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.